Hypothesis: Cyclic Yamanaka factor expression rejuvenates the SASP switch of senescent fibroblasts to restore acute hostage negotiator function

Core idea Transient, cyclic OSKM expression in aged tissue does not merely clear senescent cells; it reprograms their chromatin landscape to reinstate the early‑phase, regenerative SASP that defines successful senescence‑mediated negotiation. When this SASP switch is restored, senescent fibroblasts again recruit pro‑healing immune subsets and stimulate myofibroblast differentiation without persisting into a chronic, inflammatory state.

Mechanistic rationale Aging erodes the dynamic enhancer circuitry that governs the SASP timing. Young senescent fibroblasts exhibit open chromatin at enhancers driving PDGF‑AA, VEGF‑A, and TGF‑β1, while keeping NF‑κB‑dependent IL‑6 and IL‑1β loci in a poised but repressed state. In aged fibroblasts these enhancers become methylated and lose accessibility, biasing the SASP toward a constitutively inflammatory profile. Cyclic OSKM expression is known to transiently elevate nucleosome remodeling and DNA demethylation activity, which could re‑open regenerative enhancers and simultaneously recruit repressive complexes (e.g., HDAC3) to inflammatory loci. The result would be a restored temporal SASP: an early burst of pro‑regenerative factors followed by timely attenuation as the cell prepares for immune clearance.

Testable predictions

• In aged mouse skin, cyclic OSKM (e.g., 2 days on/5 days off for 4 weeks) will increase the proportion of p16⁺ fibroblasts that display a young‑like ATAC‑seq peak at the PDGF‑AA enhancer and reduced H3K27ac at the IL‑6 enhancer within 48 h of each induction pulse.
• SASP collected from OSKM‑treated aged wounds will show a higher ratio of PDGF‑AA/VEGF‑A to IL‑6/IL‑1β compared with untreated aged controls, matching the profile of young acute senescent fibroblasts.
• Wound closure assays will reveal accelerated healing in OSKM‑treated aged mice; this benefit will be abrogated by clodronate‑mediated macrophage depletion, indicating dependence on immune-mediated clearance of the renegotiated senescent cells.
• Chromatin immunoprecipitation for OSKM factors will show transient binding to super‑enhancers of regenerative SASP genes but not to constitutive inflammatory gene promoters during the induction window.

Falsification If cyclic OSKM fails to alter enhancer accessibility or SASP composition toward the regenerative signature, or if accelerated healing occurs independently of macrophage presence, the hypothesis that OSKM rejuvenates the hostage negotiator function would be refuted. Conversely, observing the predicted chromatin and secretory shifts coupled with immune‑dependent functional improvement would support the notion that partial reprogramming rescues senescent cell quality rather than merely reducing their quantity.

Implication This reframes partial reprogramming as a tool to repair the program of senescence, not just to eliminate senescent cells, offering a mechanistic bridge between rejuvenation strategies and the preservation of beneficial, transient senescence in tissue repair.